145 related articles for article (PubMed ID: 22246824)
1. An in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1.
Lee CK; Lee HK; Loh TP; Sethi SK; Koay ES; Tang JW
J Med Virol; 2012 Mar; 84(3):394-401. PubMed ID: 22246824
[TBL] [Abstract][Full Text] [Related]
2. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
[TBL] [Abstract][Full Text] [Related]
4. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.
Cavalcanti AM; Lacerda HR; Brito AM; Pereira S; Medeiros D; Oliveira S
Mem Inst Oswaldo Cruz; 2007 Nov; 102(7):785-92. PubMed ID: 17992369
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.
Sadeghi L; Lolaie M; Tabatabai RA; Bayanolhagh S; Taj L; Ahmadi NE; Abedinzadeh N; Vakili F; Ahmadi G; Mohraz M
Infect Disord Drug Targets; 2018; 18(3):241-248. PubMed ID: 29663899
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients.
Elmi Abar A; Jlizi A; Darar HY; Kacem MA; Slim A
Diagn Pathol; 2012 Oct; 7():138. PubMed ID: 23044036
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay.
Wilson JW; Bean P; Robins T; Graziano F; Persing DH
J Clin Microbiol; 2000 Aug; 38(8):3022-8. PubMed ID: 10921971
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
Yalçınkaya T; Köse S
Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
[TBL] [Abstract][Full Text] [Related]
11. Development, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients.
Acharya A; Vaniawala S; Shah P; Misra RN; Wani M; Mukhopadhyaya PN
PLoS One; 2014; 9(8):e105790. PubMed ID: 25157501
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance.
Van den Eede P; Van Wesenbeeck L; Verlinden Y; Feyaerts M; Smits V; Verheyen A; Vanhooren L; Deloof A; Villacian J; Pattery T
Methods Mol Biol; 2013; 1030():37-55. PubMed ID: 23821259
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
[TBL] [Abstract][Full Text] [Related]
14. A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens.
Neufeld B; Munyuza C; Reimer A; Capiña R; Lee ER; Becker M; Sandstrom P; Ji H; Cholette F
J Virol Methods; 2024 Jun; 327():114939. PubMed ID: 38604585
[TBL] [Abstract][Full Text] [Related]
15. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
[TBL] [Abstract][Full Text] [Related]
16. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
[TBL] [Abstract][Full Text] [Related]
17. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
18. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.
Seu L; Mulenga LB; Siwingwa M; Sikazwe I; Lambwe N; Guffey MB; Chi BH
J Med Virol; 2015 Jul; 87(7):1149-57. PubMed ID: 25754408
[TBL] [Abstract][Full Text] [Related]
19. Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.
Medeiros MS; Arruda EA; Guerrant RL; Brown C; Hammarskjold ML; Rekosh D; Lima AA
Braz J Infect Dis; 2007 Aug; 11(4):390-4. PubMed ID: 17873990
[TBL] [Abstract][Full Text] [Related]
20. Restriction fragment mass polymorphism (RFMP) analysis based on MALDI-TOF mass spectrometry for detecting antiretroviral resistance in HIV-1 infected patients.
Lee JH; Hachiya A; Shin SK; Lee J; Gatanaga H; Oka S; Kirby KA; Ong YT; Sarafianos SG; Folk WR; Yoo W; Hong SP; Kim SO
Clin Microbiol Infect; 2013 Jun; 19(6):E263-70. PubMed ID: 23480551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
